Category

China

Daily Brief China: Kuaishou Technology, China Resources Beer Holdings, Tongcheng Travel Holdings , West China Cement, Oriental Watch, Beijing Tong Ren Tang Healthcare Investment, J&T Global Express , Tata Motors Ltd, ATRenew and more

By | China, Daily Briefs

In today’s briefing:

  • KS / Kuaishou (1024 HK): 2Q24, Significant Margin Improvement and 100% Stock Upside
  • Beer in China: 1H2024 Low Point—What Lies Ahead?
  • Tongcheng Travel (780 HK): Seems like a Cost Issue
  • West China Cement – Earnings Flash – H1 FY 2024 Results – Lucror Analytics
  • Oriental Watch (398 HK): Sluggish Sales But Deep Value And Rolex Resilience
  • Pre-IPO Tong Ren Tang Healthcare Investment – Profitability and Growth Sustainability Are Worrying
  • J&T Global Express H124 Results: A Dramatic Turnaround? But Something Doesn’t Make Sense
  • Morning Views Asia: Tata Motors ADR, Yankuang Energy Group
  • 2Q24 Earnings: Adjusted Operating Income Beat on Higher Revenues Growth Outlook Remains Bright


KS / Kuaishou (1024 HK): 2Q24, Significant Margin Improvement and 100% Stock Upside

By Ming Lu

  • The gross margin improved 5 pp (percentage points) YoY and the operating margin improved 7 pp YoY in 2Q24.
  • In 2Q24, total revenue grew by 12% YoY, with the main business up by 22% YoY.
  • Three cross-sectional comparisons reach similar stock upsides about 100%. Buy.

Beer in China: 1H2024 Low Point—What Lies Ahead?

By Devi Subhakesan

  • Stock valuations for China’s top beer players are near historical lows, but is a recovery on the horizon? Will it ever return to the heady valuations of 2019-2020?
  • China Resources Beer Holdings (291 HK) and Budweiser Brewing APAC (1876 HK) have reported 1H2024 results showing a decline in sales volumes, attributed to several short term factors.
  • We highlight long-term factors, including an aging population and shifting consumer habits, that could limit sustained growth in China’s alcoholic beverage market.

Tongcheng Travel (780 HK): Seems like a Cost Issue

By Osbert Tang, CFA

  • Tongcheng Travel Holdings (780 HK) is still suffering from cost pressure, with adjusted net profit increased by 10.9% in 2Q24, despite a 48.1% revenue growth.
  • Both GMV and MPU growth rates have slowed in 2Q24 when compared with 1Q24, and revenue may also decelerate in 2H24 given the higher base for comparison.
  • The market will need some time to see if the moderating earnings trend will sustain, negatively affecting investor interests. Potential earnings downgrade is also a challenge.

West China Cement – Earnings Flash – H1 FY 2024 Results – Lucror Analytics

By Leonard Law, CFA

West China Cement (WCC) has released softer than expected H1/24 numbers. The company’s revenue and profitability in Mainland China continued to decline amid the real estate slump, while its performance in Africa was mixed. ​FCF remained negative and leverage continued to deteriorate. That said, liquidity appears manageable, as we expect WCC to refinance its short-term loans. The main debt maturity wall is in July 2026, when the USD 600 mn notes will come due.

In our view, the key risk is uncertainty over the extent of WCC’s overseas expansion. The company stated that it has no plans for capacity expansion in FY 2024, other than the ongoing developments in Ethiopia and Uzbekistan. However, this contradicts media reports on WCC’s investments in Rwanda, Uganda and Zimbabwe. Hence, we are unsure about the level of the company’s planned overseas capex. Going forward, cement demand in Mainland China is likely to remain weak, due to the slowdown in infrastructure investment (with lower growth) and continued decline in real estate investment.


Oriental Watch (398 HK): Sluggish Sales But Deep Value And Rolex Resilience

By Sameer Taneja

  • Hong Kong’s watch and jewelry sales were weak in Q2 CY24 (-24% YoY) as dampened sentiment continues to plague overall retail sales across regional sectors. 
  • However, Oriental Watch (398 HK), with its Rolex and Patek Phillipe portfolio, is expected to be more resilient than the rest of the watch industry. 
  • The company is still a very good dividend play, trading at 7.6x FY25 PE, with 60% of the market cap in cash and a 13.5% dividend yield. 

Pre-IPO Tong Ren Tang Healthcare Investment – Profitability and Growth Sustainability Are Worrying

By Xinyao (Criss) Wang

  • Tong Ren Tang’s performance growth is mainly driven by M&As. Its organic growth and operation management capability are not strong, leading to the concerns on the sustainability of future growth.
  • Profit margin is disappointing.If Tong Ren Tang fails to balance the interests of different parties and control costs/expenses,low profit margins will be the norm despite the growth of revenue scale.
  • From the perspectives of revenue scale, profitability, operational efficiency, business model, there’s still a gap between Tong Ren Tang and Gushengtang. Tong Ren Tang’s valuation should be lower than Gushengtang.

J&T Global Express H124 Results: A Dramatic Turnaround? But Something Doesn’t Make Sense

By Daniel Hellberg

  • J&T Global Express this week reported a strong Y/Y improvement in EBITDA
  • The most dramatic improvement came at the company’s China operation
  • But the drivers of this improvement appear odd, even contradictory; AVOID

Morning Views Asia: Tata Motors ADR, Yankuang Energy Group

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


2Q24 Earnings: Adjusted Operating Income Beat on Higher Revenues Growth Outlook Remains Bright

By Zacks Small Cap Research

  • Key 2Q24 takeaways include: 1) revenues likely to step function higher in the near term (4Q24 launch of Apple’s iPhone 16) and beyond reflecting building recycling volumes and rising demand for pre-owned products, particularly in light of ongoing government support 2) management remains focused on increasingly tapping into recycling activity beyond consumer electronics (luxury goods, gold, jewelry, premium liquor), as well as further expanding the company’s store footprint and upgrading existing locations to better showcase multi-category products and 3) we look for further margin expansion looking out to 2H24 and 2025 given a more favorable product/distribution mix.
  • From a stock perspective, we see further upside for RERE, as awareness and appreciation of the company’s business model, growth prospects, competitive positioning, and valuation disconnect increasingly take hold.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Alibaba Group Holding , China Tower , Swire Pacific (A), Huaneng Lancang River Hydropow, Wharf Real Estate Investment C, JD Logistics , China Resources Beer Holdings, Medtide, Delhi International Airport Limited and more

By | China, Daily Briefs

In today’s briefing:

  • China Consumption Weekly (19Aug2024): China Literature, BEKE, Alibaba, JD, JD Health, Tencent Music
  • FXI Rebalance Preview: China Tower (788 HK) Could Replace CICC (3908 HK)
  • HK CEO & Director Dealings (19th Aug 2024): Merlin Selling Swire Pac/Props; Chans Buying Hang Lung
  • China A50 ETFs Rebalance Preview: Two High Probability Changes in Sep
  • Wharf REIC: Beta Play W Multiple Catalysts, Lower Rates, Weaker Currency and Returning of Shoppers
  • JD Logistics (2618 HK): There Are More Rooms
  • China Resources Beer Holdings – Interim Results Show Progress but Macro Headwinds Remain
  • Pre-IPO Medtide – The Industry, the Business and the Concerns
  • Morning Views Asia: Continuum Green Energy, Melco Resorts and Entertainment (Philippines)


China Consumption Weekly (19Aug2024): China Literature, BEKE, Alibaba, JD, JD Health, Tencent Music

By Ming Lu

  • China Literature’s revenue increased by 28% YoY in 1H24, because four novel copyrights for movies brought box office hits.
  • KE revenue increased by 20% YoY in 2Q24 compared with a 19% YoY decrease in 1Q24, as government policies supported existing home transaction.
  • Alibaba announced that it will recruit 1,000 fresh graduates for tech positions in 2025.

FXI Rebalance Preview: China Tower (788 HK) Could Replace CICC (3908 HK)

By Brian Freitas


HK CEO & Director Dealings (19th Aug 2024): Merlin Selling Swire Pac/Props; Chans Buying Hang Lung

By David Blennerhassett



Wharf REIC: Beta Play W Multiple Catalysts, Lower Rates, Weaker Currency and Returning of Shoppers

By Jacob Cheng

  • Wharf REIC reported 2% yoy core earnings growth, the first earnings increase since 2019. The results also show Hong Kong retail business is more resilient than expected
  • The upcoming catalysts include 1) lower interest rates, 2) weakening currency environment and 3) bottoming out of HK retail market
  • Market is forward-looking and we think the worst is behind us.  Valuation is very compelling.  The stock is a beta play.  BUY

JD Logistics (2618 HK): There Are More Rooms

By Osbert Tang, CFA

  • Even after the 28% surge in share price since the 1H24 result, JD Logistics (2618 HK) still deserves a look as fundamentals have improved, especially with better cost control.
  • JDL is riding on scale economies with higher asset utilisation. Quarterly margins have sustained an uptrend, reaching the highest levels since 1Q21 and it will continue.
  • We like its lower reliance on JD.com (9618 HK) and net cash of HK$2.83/share (28% of the share price). There is a massive upside in consensus forecasts too.

China Resources Beer Holdings – Interim Results Show Progress but Macro Headwinds Remain

By Rikki Malik

  • The company’s strategy of premiumisation continues to be executed to plan
  • Despite the derating, investors will wait until seeing concrete signs of a turn in the Chinese consumer
  • Continues to be a liquid proxy for Chinese consumption with no technology regulation risk

Pre-IPO Medtide – The Industry, the Business and the Concerns

By Xinyao (Criss) Wang

  • Medtide relies heavily on limited number of customers to contribute performance. If there is any significant reduction in demand by its major customers, Medtide’s performance growth would be materially/adversely affected.
  • Due to geopolitical conflicts, pharmaceutical companies are becoming more cautious about their reliance on China CXO. So, the development of Medtide’s overseas business would become more uncertain in this context.
  • Medtide’s business scale is still small and its position in the global peptide CXO industry is not as strong as described. Valuation of Medtide should be lower than peers.

Morning Views Asia: Continuum Green Energy, Melco Resorts and Entertainment (Philippines)

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Weimob Inc., ASM Pacific Technology, Tencent, J&T Global Express , Hang Seng Index, Alibaba Group Holding , Wasion Group Holdings, China Traditional Chinese Medicine and more

By | China, Daily Briefs

In today’s briefing:

  • Hang Seng Internet & IT Index Rebalance: Three Changes & A Few Surprises
  • HSTECH Index Rebalance: ASMPT (522 HK) Replaces Ping An Healthcare (1833 HK)
  • Hang Seng Index Sep24 Rebal – No Name Changes, Some Capping, 1% One-Way Flow – Total 0️⃣🍔
  • HSCEI Sep24 Rebal – Two ADDs, Two DELETEs, Two Surprises, Middling Flows
  • Hang Seng Index (HSI) Rebalance: Meh (Or Will We Ever Get to 100 Stocks?)
  • [Alibaba (BABA US, BUY, TP US$100) TP Change]: On Track for the Great Turnaround…Reiterate BUY
  • Sep24 HSTECH Index Rebal – ASMPT (522 HK) ADDed as Expected, After Post-Earnings Fall
  • Time To Buy China/Gold
  • Wasion (3393): Profit Alert and OBOR Beneficiary
  • Merger Arb Mondays (19 Aug) – China TCM, Henlius, Canvest, CPMC, JTower, Fuji Soft PropertyGuru


Hang Seng Internet & IT Index Rebalance: Three Changes & A Few Surprises

By Brian Freitas

  • There will be 3 changes for the Hang Seng Internet & Information Technology Index (HSIII) at the September rebalance. There are some surprises.
  • Estimated one-way turnover at the rebalance is 3.4% resulting in a round-trip trade of HK$2.04bn (US$262m). 7 stocks will have over 1x ADV to trade.
  • Weimob Inc. (2013 HK) is a surprise add. There is 6x ADV to buy from passive trackers and shorts are 12% of shares out and 24x ADV to cover.

HSTECH Index Rebalance: ASMPT (522 HK) Replaces Ping An Healthcare (1833 HK)

By Brian Freitas


Hang Seng Index Sep24 Rebal – No Name Changes, Some Capping, 1% One-Way Flow – Total 0️⃣🍔

By Travis Lundy

  • The Hang Seng Index Committee its slow move (lack of movement) towards 100 names and sector rebalancing to tech and healthcare. This is really disappointing.
  • This time? We get nothing. No name changes. Some capping flows. 6 FAF changes. 
  • Minimal flows on the HSI rebalance to be effective on 9 September. 

HSCEI Sep24 Rebal – Two ADDs, Two DELETEs, Two Surprises, Middling Flows

By Travis Lundy


Hang Seng Index (HSI) Rebalance: Meh (Or Will We Ever Get to 100 Stocks?)

By Brian Freitas

  • In a surprise (maybe should not have been!), there are no constituent changes for the Hang Seng Index (HSI INDEX) in September. However, there are float and capping changes.
  • Estimated one-way turnover is 1% and estimated round-trip trade is HK$3.73bn (US$478m). There are no stocks with over +/-0.5x ADV to trade but flows could add to/offset other index flows.
  • We remain at 82 index constituents and the road to 100 constituents appears to be a long drawn out torturous one. At this glacial pace, could be an eternity away.

[Alibaba (BABA US, BUY, TP US$100) TP Change]: On Track for the Great Turnaround…Reiterate BUY

By Ying Pan

  • BABA reported C1Q24 top line, adjusted EBITA and non-GAAP net profit (2.7%), 5.5% and in-line vs. consensus. 
  • E-Commerce GMV recovery is the most positive of all. TTG ad-revenues (CMR) trailed GMV growth but we see the two closing the gap in C2H24
  • Besides stabilizing e-commerce, BABA is on track of transforming itself from China’s eBay to China’s Microsoft. AI-related cloud revenue grew 100% YoY. 

Sep24 HSTECH Index Rebal – ASMPT (522 HK) ADDed as Expected, After Post-Earnings Fall

By Travis Lundy


Time To Buy China/Gold

By Douglas Busch

  • Gold breaks above MONTHLY bull flag suggesting possible move to 3000.
  • Is China ready to duplicate prior move we witnessed in Nikkei?
  • BABA looks technically attractive and could reach par by year-end.

Wasion (3393): Profit Alert and OBOR Beneficiary

By Henry Soediarko

  • 1H 24 net profit is expected to grow by 54%, a similar amount to FY 23 with a consistent message that revenue growth helps and cost control is in place. 
  • Wasion Group Holdings (3393 HK) benefits from the One Belt One Road policy as many of the EM countries do not have smart power meters yet. 
  • Wasion’s holding on Willfar Information Technology (688100 CH) is worth around USD 970 million, double the current market capitalization of Wasion.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: China Traditional Chinese Medicine, Tencent, J&T Global Express , Kweichow Moutai, CMOC Group , CK Infrastructure Holdings, Shanghai Rural Commercial Bank, CPMC Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • (Mostly) Asia-Pac M&A: TCM, BusinessOn Comm, Orora, Ramsay Health Care, Namoi Cotton, APM, CPMC
  • HK Connect SOUTHBOUND Flows (To 16 Aug 2024); Big Net Buying On “Tiny” Overall Volume, ETFs Big
  • HSCEI Index Rebalance: Three In-Line Changes, Two Big Surprises
  • Mainland Connect NORTHBOUND Flows (To 16 Aug 2024): Banks Bought, Industry & Materials Sold
  • Quiddity Leaderboard SSE50/180 Dec 24: SSE 50 Expected ADDs Vs DELs Trade Looks Interesting
  • Last Week in Event SPACE: Aussie Tax Loss Basket, CK Infra, JTower, Porsche
  • [Tencent (700 HK, BUY, TP HK$485) TP Change]: Revenue Acceleration and Margin Leverages to Come
  • Quiddity Leaderboard CSI 300/​​500 Dec 24: US$4.3bn One-Way Flows; Exp.ADDs Vs DELs Rebound Possible
  • HSCI Index Rebalance: 38 Adds, 29 Deletes & Changes to Southbound Stock Connect


(Mostly) Asia-Pac M&A: TCM, BusinessOn Comm, Orora, Ramsay Health Care, Namoi Cotton, APM, CPMC

By David Blennerhassett


HK Connect SOUTHBOUND Flows (To 16 Aug 2024); Big Net Buying On “Tiny” Overall Volume, ETFs Big

By Travis Lundy

  • SOUTHBOUND was again a net buyer, for HK$16.6bn this week (now 28wks in a row of net buying), on VERY LOW two-way volumes. 
  • Gross volumes were very low. Net volumes were decent. There were three ETFs in the top 5 SOUTHBOUND net buys this past week suggesting position unwinding.
  • Top net buys other than the ETFs were China Mobile and Tencent (now 14 out of 15 days seeing net SOUTHBOUND buying)

HSCEI Index Rebalance: Three In-Line Changes, Two Big Surprises

By Brian Freitas


Mainland Connect NORTHBOUND Flows (To 16 Aug 2024): Banks Bought, Industry & Materials Sold

By Travis Lundy

  • The Quiddity Mainland Connect NORTHBOUND Monitor. Like the A/H Premium Monitor and HK Connect SOUTHBOUND Monitor. Lots of Flows/Position Tables and Charts with which to play.
  • Last week saw NORTHBOUND net SELL RMB 5.0bn of A-shares. NORTHBOUND volumes were very, very low overall.
  • HK large caps again outperformed Mainland large caps generally. Tech (HSTECH vs Star50 and ChiNext) saw even better HK outperformance.

Quiddity Leaderboard SSE50/180 Dec 24: SSE 50 Expected ADDs Vs DELs Trade Looks Interesting

By Janaghan Jeyakumar, CFA

  • SSE 50 and SSE 180, respectively, aim to represent the performance of the 50 and 180 largest and most liquid A-share stocks listed on the Shanghai Stock Exchange.
  • In this insight, we take a look at the names leading the race to become ADDs and DELs during the December 2024 index rebal event.
  • Some of our index change expectations have changed since our last insight.

Last Week in Event SPACE: Aussie Tax Loss Basket, CK Infra, JTower, Porsche

By David Blennerhassett

  • The Aussie Tax-Loss Selling Baskets worked very well on the sell side from 30 April through end-June 2024. What now?  Unwind.
  • CK Infrastructure Holdings (1038 HK) has now submitted an application for a secondary listing, not a dual-primary listing, on the London stock exchange. Admission expected on the 19th August. 
  • The right trade is to buy JTower (4485 JP) below terms. The really right trade is to already be an owner. IF you’re an arbitrageur, you know what to do.

[Tencent (700 HK, BUY, TP HK$485) TP Change]: Revenue Acceleration and Margin Leverages to Come

By Ying Pan

  • Tencent reported C2Q24 revenue, IFRS operating profit, and IFRS net income in-line, in-line, 10% vs. our estimates and in-line, in-line, 19% vs. consensus;
  • Weak fintech revenue, due to weak consumption, dragged down overall growth. But we see structural revenue acceleration and margin leverages in advertising, game and AI;
  • We raise TP to HK$485 and keep Tencent as our TOP PICK.

Quiddity Leaderboard CSI 300/​​500 Dec 24: US$4.3bn One-Way Flows; Exp.ADDs Vs DELs Rebound Possible

By Janaghan Jeyakumar, CFA

  • CSI 300 represents the 300 largest stocks by market cap and liquidity from the Shanghai and Shenzhen Exchanges. CSI 500 is the next 500.
  • In this insight, we take a look at the potential ADDs and DELs leading the race for the semiannual index rebal event in December 2024.
  • Our expected ADDs and DELs baskets have changed slightly since our last insight.

HSCI Index Rebalance: 38 Adds, 29 Deletes & Changes to Southbound Stock Connect

By Brian Freitas

  • There are 38 adds and 29 deletes for the Hang Seng Composite Index (HSCI) at the September rebalance to take the number of index constituents up to 518.
  • We expect 33 of the 38 HSCI inclusions to be added to Stock Connect while we expect 27 of the 29 HSCI deletions to be removed from Southbound Stock Connect.
  • Since the start of the calendar year, shares held though Southbound Connect have increased in 22 of the 27 HSCI deletions that will also be removed from Stock Connect.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Alibaba Group Holding , JD.com Inc (ADR), Cainiao Smart Logistics Network, Yuexiu Real Estate Investment Trust and more

By | China, Daily Briefs

In today’s briefing:

  • Alibaba (BABA US): Strategy at Work
  • JD.com (JD US):  Strong Profitability And Upsized Share Buyback in 2Q24
  • CaiNiao Q1FY Results: Most Interesting Read-Through Is Dramatic Slowdown in X-Border Activity
  • Morning Views Asia: Lenovo, Citicore Renewable Energy, Vedanta Resources
  • Morning Views Asia: Lenovo, Citicore Renewable Energy, Vedanta Resources
  • Morning Views Asia: Lenovo, Citicore Renewable Energy, Vedanta Resources
  • Morning Views Asia: Lenovo, Citicore Renewable Energy, Vedanta Resources


Alibaba (BABA US): Strategy at Work

By Eric Chen

  • Mixed June quarter results at first glance suggest corporate overhaul strategy is working, with clear evidence Taobao/Tmall is stabilizing in terms of market share and profitability.
  • Better platform monetization and clear timetable for achieving break-even by non-e-commerce business segments mean double-digit earnings CAGR by FY26 in our view.
  • We expect Alibaba’s upswing business cycle and moderating headwind of housing market slump are paving the way for the stock’s re-rating in the next 12-24 months. 

JD.com (JD US):  Strong Profitability And Upsized Share Buyback in 2Q24

By Steve Zhou, CFA

  • Profitability of the business surprised on the upside, as the net profit margin of JD.com increased from 3% in 2Q23 to 5% in 2Q24.
  • Share buyback accelerated in 2Q24, as the company bought USD2.1bn worth of stock in the quarter, up from USD1.2bn in 1Q24. 
  • The stock is trading at 7x 2024 PE, with a yield of >10% through dividend and buyback.

CaiNiao Q1FY Results: Most Interesting Read-Through Is Dramatic Slowdown in X-Border Activity

By Daniel Hellberg

  • Alibaba logistics arm CaiNiao’s revenue growth slowed in the June quarter
  • Our main takeaway is that Chinese X-border eComm continues to slow
  • We believe all of the large X-border eComm platforms may be affected

Morning Views Asia: Lenovo, Citicore Renewable Energy, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Morning Views Asia: Lenovo, Citicore Renewable Energy, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Morning Views Asia: Lenovo, Citicore Renewable Energy, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Morning Views Asia: Lenovo, Citicore Renewable Energy, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: China Traditional Chinese Medicine, Alibaba Group Holding , Midea Group Co Ltd A, KE Holdings , Jiangsu Zenergy Battery Technologies and more

By | China, Daily Briefs

In today’s briefing:

  • China Traditional Chinese Medicine (570 HK): Relief as Update Favours the Bulls
  • TCM (570 HK): A Spoonful Of Sugar …
  • Alibaba (9988 HK/BABA): 1Q25, Growth Lower Than Expectation, But Many Expansion Plans Following
  • Midea Group (000333 CH): Index Implications at US$3bn Issue Size
  • [KE Holdings Inc. (BEKE US, BUY, TP US$24) TP Change]: Market Share Gain Is the Main Catalyst
  • Jiangsu Zenergy Battery Technologies Pre-IPO Tearsheet


China Traditional Chinese Medicine (570 HK): Relief as Update Favours the Bulls

By Arun George

  • China Traditional Chinese Medicine (570 HK)’s monthly update reinforces the bull case. The gross spread has remained uncomfortably high since falling on no news on 26 June. 
  • The monthly update will relieve the bulls, as the consortium has finally made the regulatory submissions. The update stresses that the filing delay is due to an unwieldy consortium. 
  • Potential stumbling blocks remain, which should not be an issue. Nevertheless, the risk (17.7% downside to the undisturbed price)/reward (21.4% gross spread) remains attractive. 

TCM (570 HK): A Spoonful Of Sugar …

By David Blennerhassett

  • A 14.8% gain month-to-date, including this past Monday’s 6.5% pop – you just knew something positive was taking place behind closed doors. And leaking its way into the public.   
  • So it was no real surprise to read in the latest monthly update announcement on the HKEx that various regulatory approvals are almost, but not quite, satisfied.
  • The wording in the announcement strikes a positive tone. Even remaining conservative on the timeline, this could be wrapped up before year-end. 

Alibaba (9988 HK/BABA): 1Q25, Growth Lower Than Expectation, But Many Expansion Plans Following

By Ming Lu

  • Alibaba’s revenue grew by 4% YoY in 1Q25 due to the stagnancy in e-commerce.
  • However, many expansion plans follow, including overseas market, physical stores, and fresh food wholesale.
  • We set an upside of 51% and a price target of HK$115 for March 2025.

Midea Group (000333 CH): Index Implications at US$3bn Issue Size

By Brian Freitas

  • Midea Group Co Ltd A (000333 CH) has got approval to list on the HKEX (388 HK) and reports are that the listing could be up to US$3bn.
  • That issue size is around half of the maximum that the company can issue. But it would still need cornerstone investors and a nice discount on the H-shares.
  • The stock will still get included in some indices even with the scaled down size, and inclusion in Southbound Stock Connect is a given.

[KE Holdings Inc. (BEKE US, BUY, TP US$24) TP Change]: Market Share Gain Is the Main Catalyst

By Eric Wen

  • KE Holdings (BEKE) reported C2Q24 revenue 12%/9% higher than our estimates/consensus, and non-GAAP NI 19%/49% higher than our estimates/consensus, due to market share gain and take rate hike.
  • We particularly like its business scalability, as its agent efficiency kept stable despite growing connected agents.
  • We maintain the stock as BUY rating and raise TP to US$24 to reflect the better growth outlook from market share gains.

Jiangsu Zenergy Battery Technologies Pre-IPO Tearsheet

By Ethan Aw

  • Jiangsu Zenergy Battery Technologies (JSZENERGY CH) is looking to raise up to US$300m in its upcoming HK IPO. The deal will be run by CICC, and CMB International.
  • Jiangsu Zenergy Battery Technologies (Zenergy from hereon) is an EV and energy storage system (ESS) battery manufacturer in China. 
  • It provides integrated battery solutions, encompassing battery cells, modules, packs, racks, and battery management systems dedicated to large-scale applications of electrochemical products to interconnect omni-scenarios of land, sea and air.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Tencent, Midea Group Co Ltd A, Fu Shou Yuan, TAL Education and more

By | China, Daily Briefs

In today’s briefing:

  • Tencent (700 HK): 2Q24, Gross Margins of All Business Lines Improved Significantly
  • Tencent 2Q: Recent Launch of DnF Mobile Helps Domestic Gaming Return to Growth
  • Midea A/H Listing – Getting Closer to the US$3bn+ Raising, Has a Narrow Window
  • Fu Shou Yuan (1448.HK) – Negative Growth in 24H1 Seems Inevitable
  • TAL Education Group: A Tale Of Expansion and Diversification in Learning Devices! – Major Drivers


Tencent (700 HK): 2Q24, Gross Margins of All Business Lines Improved Significantly

By Ming Lu

  • Total revenue increased by 8% YoY in 2Q24, lightly higher than 1Q24 and 4Q23.
  • The gross margins of all business lines Improved significantly YoY.
  • We set the upside at 35% and the price target at HK$506 for the end of 2025. Buy.

Tencent 2Q: Recent Launch of DnF Mobile Helps Domestic Gaming Return to Growth

By Shifara Samsudeen, ACMA, CGMA

  • Tencent (700 HK) reported 2Q2024 results today which beat consensus. Domestic gaming resumed growth driven by the successful launch of DnF Mobile which continues to dominate charts in China.
  • All three business segments saw improvement in margins driven by Tencent’s high-margin businesses incl. mini-programs, video accounts, short-videos, etc.
  • We expect continued recovery in Tencent’s earnings, however, remain cautious given slowdown in consumption spending and macroeconomic uncertainties.

Midea A/H Listing – Getting Closer to the US$3bn+ Raising, Has a Narrow Window

By Sumeet Singh

  • Midea Group Co Ltd A (000333 CH) one of the world’s largest home appliance producers, aims to raise up to US$3bn in its H-share listing.
  • Midea Group is one of the world’s largest home appliance manufacturing companies with a presence in over 200 countries. Its A-shares have been listed since 2013.
  • We have covered the company and deal background in our previous notes. In this note, we talk about the updates since then.

Fu Shou Yuan (1448.HK) – Negative Growth in 24H1 Seems Inevitable

By Xinyao (Criss) Wang

  • According to the management, the performance of 24H1 should be better than that of 21H1, but Fu Shou Yuan’s performance in 2024 full year may still fall short of expectations.
  • In the future, the development strategy of Fu Shou Yuan would rely more on endogenous growth. Without aggressive M&A, long-term revenue growth rate could fall to single digit.
  • Special dividends will continue in the future. However, one major risk for Fu Shou Yuan is policy risk. The bottom line is the demand for the funeral industry always exists.

TAL Education Group: A Tale Of Expansion and Diversification in Learning Devices! – Major Drivers

By Baptista Research

  • TAL Education Group delivered a robust set of results in its fiscal first quarter of 2025, showcasing significant revenue growth and strategic expansions in both its learning services and content solutions sectors.
  • These outcomes reflect the company’s focused execution on its operational strategies and its adaptability to the evolving educational needs.
  • Financially, TAL Education Group reported a net revenue of USD 414.2 million, a substantial increase of 50.4% from the previous year, paralleled by a 56.9% increase in RMB terms.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: ASM Pacific Technology, CPMC Holdings, Greatview Aseptic Packaging, Tencent, PICC Property & Casualty H, WeRide, Pop Mart International Group L, Yuexiu Property and more

By | China, Daily Briefs

In today’s briefing:

  • HSCEI/HSTECH/HSIII Index Rebalance Preview: Potential Changes, Flow & Positioning
  • CPMC Holdings (906 HK): A Carefully Caveated Board Recommendation of Changping Industrial’s Offer
  • Greatview Aseptic Packaging (468.HK) – The Story Behind The “Hostile Offer”
  • Quiddity Leaderboard HSTECH Sep 24: Expected ADD and DEL Have 10+ Days to Trade
  • Tencent to Report 2Q FY24 Results (What Is Priced?), MSC Index Changes for Aug Rebalance Published
  • Quiddity Leaderboard HSCEI Sep 24: Announcement Soon; Updated Flow Expectations and Trade Idea
  • WeRide IPO – Stiff Competition and Bleak Sentiment.  Premium Valuation Doesn’t Help
  • WeRide IPO: High-Risk Venture Investment and Unproven Business Model
  • BUY/SELL/HOLD: Hong Kong Stock Updates (August 12)
  • Morning Views Asia: Guangzhou R&F Properties, JSW Steel Ltd, Yuexiu Property


HSCEI/HSTECH/HSIII Index Rebalance Preview: Potential Changes, Flow & Positioning

By Brian Freitas


CPMC Holdings (906 HK): A Carefully Caveated Board Recommendation of Changping Industrial’s Offer

By Arun George

  • The CPMC Holdings (906 HK) Board recommends that shareholders accept Changping Industrial’s HK$6.87 offer, which the IFA opines is fair and reasonable.
  • The Board’s carefully crafted and suitably caveated recommendation acknowledges that shares continue to trade through terms and ORG Technology Co., Ltd. A (002701 CH)’s HK$7.21 offer is higher but preconditional. 
  • Based on ORG’s shareholding/irrevocable and volume traded above terms, Changping Industrial’s offer has little chance of success. It remains a question of when, not if, Changping Industrial will bump.

Greatview Aseptic Packaging (468.HK) – The Story Behind The “Hostile Offer”

By Xinyao (Criss) Wang

  • The connection between Newjf and Greatview is deep. Newjf expressed an interest in acquiring Greatview early on, but the two parties didn’t reach an agreement. Greatview is not entirely “innocent”.
  • Newjf’s decision to forcibly acquire Greatview at this moment should be made after careful consideration. Mengniu may not necessarily oppose this merger. Mengniu is likely to take a neutral stance. 
  • Newjf’s Offer is attractive. In the absence of a more realistic action by Greatview to make a higher Offer, we advise investors not to walk away from Newjf’s Offer easily.

Quiddity Leaderboard HSTECH Sep 24: Expected ADD and DEL Have 10+ Days to Trade

By Janaghan Jeyakumar, CFA

  • The HSTECH Index tracks the performance of the top 30 technology companies listed in Hong Kong that have high business exposure to certain technology themes.
  • There could be one index change during the September 2024 index rebal event. The official results will be announced after market close on 16th August 2024.
  • In this insight, we take a look at our latest flow expectations based on closing prices on Monday 12th August 2024.

Tencent to Report 2Q FY24 Results (What Is Priced?), MSC Index Changes for Aug Rebalance Published

By Charlotte van Tiddens, CFA

  • Last night, MSC published index changes due at the August rebalance. There will be no changes to SA constituents.
  • The rebalance is set to take place at the end of the month on Friday the 30th.
  • Tomorrow after the HK close, Tencent is expected to report results for 2Q FY24.

Quiddity Leaderboard HSCEI Sep 24: Announcement Soon; Updated Flow Expectations and Trade Idea

By Janaghan Jeyakumar, CFA

  • The HSCEI serves as a benchmark to reflect the overall performance of the top 50 “Mainland China” securities listed in Hong Kong.
  • The index changes and indicative weights for the September 2024 index rebal event is expected to be announced after market close on Friday 16th August 2024.
  • In this insight, we take a look at our latest expectations for capping flows based on current prices.

WeRide IPO – Stiff Competition and Bleak Sentiment.  Premium Valuation Doesn’t Help

By Clarence Chu

  • WeRide (WRD US) is looking to raise US$119m in its US IPO.
  • WeRide provides autonomous driving products and services from L2 to L4 of driving automation.
  • We had looked at the firm’s past performance in our earlier notes. In this note, we discuss our thoughts on valuation.

WeRide IPO: High-Risk Venture Investment and Unproven Business Model

By Andrei Zakharov

  • WeRide, a pure-play autonomous driving company with operations in 7 countries, may raise up to $120M in upcoming IPO in the United States.
  • WeRide is expected to IPO this week. The company’s amended prospectus puts the price range per ADS at $15.50 to $18.50, implying a market cap of ~$4.6B at the midpoint.
  • The company has raised ~$1.4B in equity financing to date and was backed by Qiming Venture Partners and the venture capital fund of the Renault Nissan Mitsubishi Alliance, among others.

BUY/SELL/HOLD: Hong Kong Stock Updates (August 12)

By David Mudd


Morning Views Asia: Guangzhou R&F Properties, JSW Steel Ltd, Yuexiu Property

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Tencent, Yum China Holdings , Giant Biogene, CPMC Holdings, Guangzhou Automobile Group, WeRide, Alibaba Group Holding , BYD and more

By | China, Daily Briefs

In today’s briefing:

  • Tencent (700 HK): 2Q24 Preview, Both Growth and Margin to Improve
  • The Heat Is On: News Flow and Sentiment in CHINA / HONG KONG (August 10)
  • Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for September
  • HK Connect SOUTHBOUND Flows (To 9 Aug 2024); Tencent the Big Buy Again
  • CPMC (906 HK) Responds To Champion’s Offer
  • A/H Premium Tracker (To 9 Aug 2024): Global Market Vol. SB Bought. NB Sold. Premia Down.
  • WeRide (WRD US) IPO: The Bear Case
  • Alibaba (BABA US): 1Q25 Preview, Stable Growth and Margin, But Overly Impacted
  • China Consumption Weekly (12 Aug 2024): Geely, Li Auto, JD.com, Alibaba, Tencent, DDL
  • Mainland Connect NORTHBOUND Flows (To 9 Aug 2024): Back to Net Selling of Renewables and Consumer


Tencent (700 HK): 2Q24 Preview, Both Growth and Margin to Improve

By Ming Lu

  • We believe total revenue will grow by 9% YoY and game revenue began to rise in 2Q24.
  • We believe the operating margin will continue to improve YoY in 2Q24 after the seven-year high in 1Q24.
  • We set the upside at 35% and the price target at HK$496 for the end of 2025.

The Heat Is On: News Flow and Sentiment in CHINA / HONG KONG (August 10)

By David Mudd


Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for September

By Brian Freitas

  • Post market close on Friday, Hang Seng Indexes will announce the changes for the Hang Seng Index (HSI INDEX) that will be implemented at the close on 6 September.
  • With no constituent changes in March and 1 add/1 delete in June, there could be more changes in September with Health Care stocks among the potential inclusions.
  • Changes to the Hang Seng Industry Classification System (HSICS) will be implemented from the September rebalance and that will alter industry coverage.

HK Connect SOUTHBOUND Flows (To 9 Aug 2024); Tencent the Big Buy Again

By Travis Lundy

  • SOUTHBOUND was again a net buyer, for HK$15.2bn this week (now 27wks in a row of net buying), on smallish two-way volumes. Better than the previous month but still low.
  • Bank net buying, which had spiked the previous week, didn’t follow through.
  • There were three ETFs in the top 15 SOUTHBOUND net buys this past week, reversing last week, which reversed the week before’s flows.

CPMC (906 HK) Responds To Champion’s Offer

By David Blennerhassett

  • On the 30th July 2024, packaging play CPMC Holdings (906 HK) dispatched the Composite Document for the HK$6.87/share, in cash, Offer from SASAC/NCSSF-backed Champion.
  • The Response Document, including the IFA opinion (with a fair & reasonable conclusion) has now been dispatched. 
  • However, the focus remains on ORG Technology Co., Ltd. A (002701 CH)‘s superior HK$7.21/share Offer, which is currently negotiating the necessary regulatory approvals. 

A/H Premium Tracker (To 9 Aug 2024): Global Market Vol. SB Bought. NB Sold. Premia Down.

By Travis Lundy

  • Delayed this week because of the long (Japanese holiday, which I took for myself) weekend, as were the SOUTHBOUND and NORTHBOUND monitors. 
  • SOUTHBOUND inflow strong. Tencent strong inflows. Net buying every day for two weeks. NORTHBOUND outflows large. Record foreign investor outflows from China’s capital markets this year.
  • As expected (with AH 20d Premia returns at multi-year highs last week), AH Premia fell slightly, with narrow premia falling more than wide premia. I’d expect more H-vs-A gains.

WeRide (WRD US) IPO: The Bear Case

By Arun George

  • WeRide (WRD US), a provider of autonomous driving products and services, seeks to raise up to US$119 million through a Nasdaq IPO and US$321 million through a concurrent private placement.
  • In WeRide (WRD US) IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on a volatile revenue profile, high customer concentration risk, widening losses that raise doubts on the path to profitability, elongated cash collection cycles and cash burn.

Alibaba (BABA US): 1Q25 Preview, Stable Growth and Margin, But Overly Impacted

By Ming Lu

  • We believe revenue will increase by 8% YoY in 1Q25, as most business lines have been growing.
  • We believe the operating margin will be stable, as cost cut plans came to an end.
  • We set an upside of 94% for March 2025, as we believe the stock is overly impacted.

China Consumption Weekly (12 Aug 2024): Geely, Li Auto, JD.com, Alibaba, Tencent, DDL

By Ming Lu

  • The retail deliveries of NEV (new energy vehicle) increased by 37% YoY in July.
  • One of Alibaba’s supermarket chains, Freshippo, will sell its OEM goods, on Lazada.
  • Tencent will formally start the game, Arena Breakout: Infinite, in August.

Mainland Connect NORTHBOUND Flows (To 9 Aug 2024): Back to Net Selling of Renewables and Consumer

By Travis Lundy

  • The Quiddity Mainland Connect NORTHBOUND Monitor. Like the A/H Premium Monitor and HK Connect SOUTHBOUND Monitor. Lots of Flows/Position Tables and Charts with which to play.
  • Last week saw NORTHBOUND net SELL RMB 14.8bn of A-shares. It was a big net sell week in relatively low gross NORTHBOUND volume.
  • HK large caps outperformed Mainland large caps generally. Tech (HSTECH vs Star50 and ChiNext) saw even better HK outperformance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: China Traditional Chinese Medicine, Swire Properties, CanSino Biologics , Plover Bay Technologies, BeiGene , Pacific Basin Shipping, China Resources Beverage, Zylox-Tonbridge Medical Technology, Shui On Land and more

By | China, Daily Briefs

In today’s briefing:

  • Merger Arb Mondays (12 Aug) – China TCM, Canvest, GA Pack, Fuji Soft, Fancl, Descente, Takiron
  • Swire Properties (1972 HK): Buyback to Offset Passive Selling
  • China Healthcare Weekly (Aug.11) – 2024 NRDL Negotiation, China Biotech Outlook, Bottom Fish CanSino
  • Shortlist Of High Conviction Ideas: Income, Value, and Margin of Safety – August 2024
  • BeiGene (6160.HK/BGNE.US) 24Q2 – It Is Time to Open a New Chapter in China’s Pharmaceutical Industry
  • Pacific Basin (2343 HK): Looking for a 2H24 Upturn
  • ECM Weekly (12th Aug 2024) – Ola Electric, Brainbees, WeRide, Akum, CR Beverages, Eternal Beauty
  • Zylox-Tonbridge Medical Technology (2190.HK) – A Good Alpha-Generating Opportunity for Investors
  • Morning Views Asia: Adani Green Energy, New World Development, Rakuten, Shui On Land
  • Morning Views Asia: Adani Green Energy, New World Development, Rakuten, Shui On Land



Swire Properties (1972 HK): Buyback to Offset Passive Selling

By Brian Freitas

  • Swire Properties (1972 HK) was trending lower on expectations of deletion from a global index in August. Short interest has jumped a lot over the last few months.
  • The announcement of the buyback last week took the stock higher. The increased real float from the index deletion will be offset by the buyback.
  • Swire Pacific (A) (19 HK)‘s ownership of Swire Properties (1972 HK) will increase from 82% to 83.5% following the buyback and cancellation of the shares. Privatisation at some point?

China Healthcare Weekly (Aug.11) – 2024 NRDL Negotiation, China Biotech Outlook, Bottom Fish CanSino

By Xinyao (Criss) Wang

  • We summarized the varieties that would miss 2024 NRDL negotiation and have to wait until 2026 to enter medical insurance coverage. This however means competing products would have more advantages.
  • As the NRDL negotiation becomes more transparent/reasonable, there will be a balance point among companies’ profits, patient affordability and medical insurance budget. So, there’s no need to be overly pessimistic.
  • The approval process of CanSino’s PCV13i could be faster than expected. 2024 is the best time to bottom-fish this stock. Reasonable market value is at least RMB5 billion.

Shortlist Of High Conviction Ideas: Income, Value, and Margin of Safety – August 2024

By Sameer Taneja


BeiGene (6160.HK/BGNE.US) 24Q2 – It Is Time to Open a New Chapter in China’s Pharmaceutical Industry

By Xinyao (Criss) Wang

  • BeiGene’s 24Q2 results far exceeded expectations. Sales of BRUKINSA may exceed that of Calquence for the first time next year. Breakeven in 2024 becomes possible if effective cost control continues.
  • BeiGene’s 2024 revenue could exceed Hengrui, marking the official transition of China’s innovative pharmaceutical industry from the old generation to the new one. Reasonable market value for BeiGene is US$19-27.5bn.
  • Current valuation cannot reflect strong fundamentals.As BeiGene has established a convincing profit model, the market turmoil actually provides investors with a good opportunity to buy the stock at low price.

Pacific Basin (2343 HK): Looking for a 2H24 Upturn

By Osbert Tang, CFA

  • Pacific Basin Shipping (2343 HK) may realise at least US$60m of revenue, or around 10% higher total TCE, in 2H24, based on its solid forward vessel coverage.  
  • Sustained re-routing of vessels due to Middle East tension and higher demand from China due to fixed asset spending are supportive of rates. FFA is now 3-4% higher than spot.
  • The stock is inexpensive at 9.7x PER and 0.8x P/B, and its 7.6% dividend yield is attractive. A solid balance sheet also means an upside on the payout ratio. 

ECM Weekly (12th Aug 2024) – Ola Electric, Brainbees, WeRide, Akum, CR Beverages, Eternal Beauty

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, the prior week witnessed a number of listings with divergent results.
  • Given the market volatility, there was only one large placements in the prior week.

Zylox-Tonbridge Medical Technology (2190.HK) – A Good Alpha-Generating Opportunity for Investors

By Xinyao (Criss) Wang

  • Zylox is a beneficiary of VBP and it has turned losses into profits. 2024 full-year revenue could be up 40-50% YoY. Net profit could be close to RMB100 million.
  • Whether in terms of the number of products on the market or the efficiency of R&D, Zylox’s performance is superior to peers.Its valuation is expected to be higher than peers.
  • We’re in a bear market, together with weak liquidity, Zylox’s valuation doesn’t fully reflect its strong fundamentals. So, while this is a good company, investors may need to be patient.

Morning Views Asia: Adani Green Energy, New World Development, Rakuten, Shui On Land

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Morning Views Asia: Adani Green Energy, New World Development, Rakuten, Shui On Land

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars